Table 5

Male cancer mortality (raw numbers (n), percentages (%), crude mortality rate (CMR) and standardised mortality rate ratio (SMR) with 95% CI), for underlying cause of death as cancer

Cancer categoryIntellectual disabilitiesGeneral populationSMR (95% CI)
N%CMRN%CMR
Number of underlying cause cancer deaths223100.0291.29537100.0431.71.07 (0.92 to 1.24)
Digestive organs6830.588.8259927.3117.61.15 (0.88 to 1.50)
 Colorectal3214.341.88959.440.5 1.59 (1.08 to 2.33)
 Oesophageal156.719.6 u5315.624.01.19 (0.67 to 2.13) u
 Stomach94.011.8 u3323.515.01.23 (0.60 to 2.53) u
 Pancreas73.19.1 u3894.117.60.85 (0.38 to 1.94) u
 Liver<53283.414.9
Respiratory and intrathoracic organs3616.147234424.6106.10.71 (0.49 to 1.01)
 Lung3214.341.8223123.4101.0 0.66 (0.45 to 0.97)
Metastatic cancer of unknown primary origin219.727.43273.414.8 2.84 (1.76 to 4.58)
Urinary tract146.318.3 u5105.323.10.95 (0.54 to 1.66) u
 Kidney83.610.5 u1801.98.21.38 (0.66 to 2.90) u
 Bladder52.26.5 u2772.912.50.71 (0.28 to 1.80) u
Haematopoietic156.719.6 u5395.724.41.26 (0.71 to 2.23) u
 Hodgkin’s and non-Hodgkin’s lymphoma62.77.8 u2192.39.91.09 (0.47 to 2.52) u
 Lymphoid leukaemia<5490.52.2
 Myeloid leukaemia<5911.04.1
 Leukaemia of unspecified cell type<5<5
Male genital organs125.415.7 u7678.034.81.10 (0.60 to 2.01) u
 Prostate104.513.1 u7417.833.60.97 (0.51 to 1.87) u
 Testicular<5910.00.4 u
Lip, oral cavity and pharynx62.77.8 u2562.711.60.79 (0.34 to 1.86) u
Central nervous system<52152.39.7
Mesothelial and soft tissue<51862.08.4
Melanoma (skin)<5880.94
Non-melanoma skin <5 466 0.2 21.1
Thyroid and other endocrine glands<5120.10.5 u
 Thyroid<560.1%0.3 u
Bone and articular cartilage<5140.1%0.6 u
  • Non-melanoma skin cancers were not included in the rate calculations in the denominator. Figures in bold are statistically significant at 5% level.

  • CMR are reported per 100 000 person-years and SMR are age-standardised rate ratios.

  • U, unreliable age–sex-standardisation due to n<20 cases.